NO304774B1 - Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater - Google Patents

Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater

Info

Publication number
NO304774B1
NO304774B1 NO934759A NO934800A NO304774B1 NO 304774 B1 NO304774 B1 NO 304774B1 NO 934759 A NO934759 A NO 934759A NO 934800 A NO934800 A NO 934800A NO 304774 B1 NO304774 B1 NO 304774B1
Authority
NO
Norway
Prior art keywords
derivatives
mixtures containing
tetrahydrocarbazole
pharmaceutical mixtures
pharmaceutical
Prior art date
Application number
NO934759A
Other languages
English (en)
Norwegian (no)
Other versions
NO934800L (no
NO934800D0 (no
Inventor
Francis David King
Laramie Mary Gaster
Alberto Julio Kaumann
Rodney Christopher Young
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO304774(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO934800L publication Critical patent/NO934800L/no
Publication of NO934800D0 publication Critical patent/NO934800D0/no
Publication of NO304774B1 publication Critical patent/NO304774B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO934759A 1991-06-26 1993-12-23 Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater NO304774B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
US08/167,846 US5464864A (en) 1991-06-26 1992-06-17 Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists
PCT/GB1992/001082 WO1993000086A1 (fr) 1991-06-26 1992-06-17 Utilisation de derives de tetrahydrocarbazone comme agonistes de recepteurs du type 5-ht¿1?

Publications (3)

Publication Number Publication Date
NO934800L NO934800L (no) 1993-12-23
NO934800D0 NO934800D0 (no) 1993-12-23
NO304774B1 true NO304774B1 (no) 1999-02-15

Family

ID=10697363

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934759A NO304774B1 (no) 1991-06-26 1993-12-23 Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater
NO2005011C NO2005011I2 (no) 1991-06-26 2005-05-03 Frovatriptan

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2005011C NO2005011I2 (no) 1991-06-26 2005-05-03 Frovatriptan

Country Status (35)

Country Link
US (2) US5464864A (fr)
EP (1) EP0591280B1 (fr)
JP (1) JP3261502B2 (fr)
KR (1) KR100251571B1 (fr)
CN (1) CN1034072C (fr)
AP (1) AP344A (fr)
AT (1) ATE170746T1 (fr)
BR (2) BR9206237A (fr)
CA (1) CA2113726C (fr)
CZ (3) CZ282327B6 (fr)
DE (2) DE69226953T2 (fr)
DK (1) DK0591280T3 (fr)
FI (1) FI103967B (fr)
GB (1) GB9113802D0 (fr)
HK (1) HK1014669A1 (fr)
HU (1) HU218907B (fr)
IE (1) IE922062A1 (fr)
IL (4) IL117105A0 (fr)
LU (1) LU90939I2 (fr)
MA (1) MA22563A1 (fr)
MX (1) MX9203444A (fr)
NL (1) NL300103I2 (fr)
NO (2) NO304774B1 (fr)
NZ (1) NZ243288A (fr)
PL (3) PL169392B1 (fr)
PT (1) PT100620B (fr)
RU (1) RU2137474C1 (fr)
SA (1) SA92130141B1 (fr)
SG (1) SG47877A1 (fr)
SI (1) SI9200125B (fr)
SK (3) SK280906B6 (fr)
TW (1) TW214544B (fr)
UA (1) UA41254C2 (fr)
WO (1) WO1993000086A1 (fr)
ZA (1) ZA924658B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
CA2179678A1 (fr) * 1995-06-23 1996-12-24 Michael Edward Flaugh Derives de substitution en 6 de 1,2,3,4-tetrahydro-9h-carbazole et de derives de substitution en 7 de 10h-cyclohepta¬7,6-b|indole
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
CN100378108C (zh) 2002-06-21 2008-04-02 苏文生命科学有限公司 对血清素受体具有亲和力、可用作治疗剂的新型四环芳基磺酰吲哚、其制备方法及其药物组合物
PT1567492E (pt) 2002-11-28 2013-07-22 Suven Life Sciences Ltd N-arilsulfonil-3-aminoalcoxi-indóis
EP1581492B1 (fr) 2002-11-28 2008-07-16 Suven Life Sciences Limited Indoles n-arylsulfonyl-3-substitues presentant une affinite pour le recepteur de la serotonine, methode de preparation et composition pharmaceutique contenant ces indoles
WO2004055026A1 (fr) 2002-12-18 2004-07-01 Suven Life Sciences Limited Indoles tetracycliques 3-substitues a affinite pour le recepteur de serotonine
CA2658986C (fr) * 2006-08-07 2014-11-25 Actelion Pharmaceuticals Ltd Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique
EP2813144A1 (fr) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Compositions analgésiques comprenant un antihistaminique
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2010073253A1 (fr) * 2008-12-22 2010-07-01 Natco Pharma Limited Procédé de préparation de frovatripan optiquement actif
CA2767576C (fr) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Compositions pharmaceutiques refermant un antiemetique et un analgesiqueopioide
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
US9204906B2 (en) 2009-10-22 2015-12-08 Nuvasive, Inc. Posterior cervical fusion system and techniques
WO2013016223A2 (fr) 2011-07-22 2013-01-31 The University Of Chicago Traitements de la migraine et de troubles apparentés
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
EP2816030A1 (fr) 2013-06-20 2014-12-24 Duke Chem, S. A. Procédés de préparation de frovatriptan et ses énantiomères
GB201312768D0 (en) 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
EP3423041A4 (fr) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Compositions pharmaceutiques
EP3766483A1 (fr) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un triptane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (fr) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Dérivés de tétrahydrocarbazole

Also Published As

Publication number Publication date
NO934800L (no) 1993-12-23
ZA924658B (en) 1993-12-24
AP9200403A0 (en) 1992-07-31
AU1977592A (en) 1993-01-25
GB9113802D0 (en) 1991-08-14
IL117104A (en) 1997-09-30
MA22563A1 (fr) 1992-12-31
DE10299042I1 (de) 2003-02-20
UA41254C2 (uk) 2001-09-17
IL117105A (en) 1998-01-04
NL300103I2 (nl) 2003-02-03
CA2113726C (fr) 2008-02-19
CN1069726A (zh) 1993-03-10
FI103967B1 (fi) 1999-10-29
EP0591280A1 (fr) 1994-04-13
PT100620A (pt) 1993-09-30
US5464864A (en) 1995-11-07
SI9200125A (en) 1992-12-31
PL171034B1 (en) 1997-02-28
DK0591280T3 (da) 1999-02-15
NL300103I1 (nl) 2002-12-02
RU2137474C1 (ru) 1999-09-20
NO2005011I2 (no) 2008-02-11
CZ282083B6 (cs) 1997-05-14
CZ150696A3 (en) 1997-06-11
IE922062A1 (en) 1992-12-30
BR1100460A (pt) 2000-07-18
CZ282061B6 (cs) 1997-05-14
BR9206237A (pt) 1995-04-11
NO2005011I1 (no) 2005-05-18
AU652842B2 (en) 1994-09-08
EP0591280B1 (fr) 1998-09-09
MX9203444A (es) 1993-12-01
SK280905B6 (sk) 2000-09-12
CN1034072C (zh) 1997-02-19
ATE170746T1 (de) 1998-09-15
NO934800D0 (no) 1993-12-23
US5637611A (en) 1997-06-10
DE10299042I2 (de) 2005-02-03
SA92130141B1 (ar) 2005-12-18
WO1993000086A1 (fr) 1993-01-07
SI9200125B (en) 2001-12-31
HUT68961A (en) 1995-08-28
PT100620B (pt) 1999-01-29
CA2113726A1 (fr) 1993-01-07
PL169392B1 (pl) 1996-07-31
CZ150596A3 (en) 1997-05-14
IL102322A (en) 1997-09-30
DE69226953T2 (de) 1999-05-12
SK280906B6 (sk) 2000-09-12
TW214544B (fr) 1993-10-11
HK1014669A1 (en) 1999-09-30
SK131993A3 (en) 1994-06-08
SK280907B6 (sk) 2000-09-12
PL169410B1 (pl) 1996-07-31
CZ282327B6 (cs) 1997-06-11
NZ243288A (en) 1994-09-27
KR100251571B1 (ko) 2000-07-01
JP3261502B2 (ja) 2002-03-04
IL117105A0 (en) 1996-06-18
FI935842A0 (fi) 1993-12-23
FI935842A (fi) 1993-12-23
IL102322A0 (en) 1993-01-14
JPH06508827A (ja) 1994-10-06
DE69226953D1 (de) 1998-10-15
HU218907B (hu) 2000-12-28
CZ286193A3 (en) 1994-07-13
SG47877A1 (en) 1998-04-17
LU90939I2 (fr) 2002-09-24
FI103967B (fi) 1999-10-29
IL117104A0 (en) 1996-06-18
AP344A (en) 1994-07-05

Similar Documents

Publication Publication Date Title
NO304774B1 (no) Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater
NO305802B1 (no) Nye forbindelser, farmas°ytiske blandinger inneholdende disse og anvendelse av disse forbindelser
NO303638B1 (no) Kondenserte indolderivater, farmas°ytiske preparater inneholdende disse og anvendelse av derivatene
NO942720D0 (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
NO180232C (no) Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler
FI943570A (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
NO891122D0 (no) Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
NO922998D0 (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
DK114189D0 (da) Benzocycloheptenderivater, samt laegemidler med indhold af saadanne forbindelser
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK578589D0 (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
NO933399D0 (no) Anordning og fremstilling av syntesegass, samt anvendelseav anordningen
DK606488D0 (da) Pyridoxyl-hydrazon-derivater og farmaceutiske forbindelser indeholdende disse
IS1813B (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO923808L (no) Substituert sulfonamidderivat og farmasoeytisk formuleringinneholdende det samme
NO924516D0 (no) Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO922812D0 (no) Naftyridin- og kinolizinderivater og farmasoeytiske preparater inneholdende disse
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: TIGREAT; NAT. REG. NO/DATE: NO , 200410482 20050222; FIRST REG. NO/DATE: FR , 92 20010419

Spc suppl protection certif: SPC/NO 2005 011

Filing date: 20050503

Extension date: 20160419

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: TIGREAT; NAT. REG. NO/DATE: NO , 200410482 20050222; FIRST REG. NO/DATE: FR , 92 20010419

Spc suppl protection certif: 2005011

Filing date: 20050503

Extension date: 20160419

MK1K Patent expired
SPCX Expiry of an spc

Free format text: PRODUCT NAME: FROVATRIPTAN

Spc suppl protection certif: 2005011

Effective date: 20160419